Ajanta Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: AJANTPHARM BSE: 532331

About Ajanta Pharma Limited

Ajanta Pharma Limited (APL) is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973..

Source: Wikipedia

Key facts

BSE symbol532331
NSE symbolAJANTPHARM
ISININE031B01049
CINL24230MH1979PLC022059
Listing date29 May 2000
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorD.G.Prajapati & Associates (Dharmendra Prajapati)
Registered officeAjanta Tower, 54-A, M Vasanji Road, Chakala, Andheri (E), Mumbai 400 093
Registrar & transfer agentMUFG Intime India Private Limited C 101, 247 Park, L B S Marg, Vikhroli West, Mumbai 400 083

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)5,050†4,442†4,102†3,592†3,280†
Net profit947917807559720†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Madhusudan B. AgrawalExecutive DirectorJune 30, 2026
Rajesh Mannalal AgrawalExecutive DirectorJune 30, 2026
Yogesh Mannalal AgrawalExecutive DirectorJune 30, 2026
David RasquinhaIndependent DirectorJune 30, 2026
Medha Vinay JoshiIndependent DirectorJune 30, 2026
Rajesh Shashikant DalalIndependent DirectorJune 30, 2026
Simi Manohar Lal ThaparIndependent DirectorJune 30, 2026
Mannalal B. AgrawalNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.